z-logo
Premium
Treatment of disseminated granuloma annulare with a 5‐lipoxygenase inhibitor and vitamin E
Author(s) -
Smith K.J.,
Norwood C.,
Skelton H.
Publication year - 2002
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1046/j.1365-2133.2002.04590.x
Subject(s) - granuloma annulare , lipoxygenase , medicine , dermatology , arachidonate 5 lipoxygenase , vitamin , pharmacology , chemistry , enzyme , biochemistry , arachidonic acid
Summary Histologically, granuloma annulare (GA) is a common non‐infectious necrobiotic granulomatous reaction pattern that correlates with a number of different, but relatively specific clinical presentations. The cause or causes of GA are unknown: when localized, it is usually self‐limiting, but it may be persistent when disseminated. We present three women who had had disseminated GA for more than 1 year. One patient had previously been treated with isotretinoin with no response. All three patients were treated with vitamin E 400 IU daily and zileuton 2400 mg daily. All responded within 3 months with complete clinical clearing. The anti‐inflammatory and immune regulatory effects of vitamin E and zileuton may be an effective treatment in some patients with prolonged disseminated/generalized GA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom